Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study
Cohen, Calvin J, Kubota, Marshall, Brachman, Philip S, Harley, William B, Schneider, Stefan, Williams, Vanessa C, Sutherland-Phillips, Denise H, Lim, Michael L, Balu, Rukmini B, Shaefer, Mark S
Published in Pharmacotherapy (01.03.2008)
Published in Pharmacotherapy (01.03.2008)
Get more information
Journal Article
NO ON E: FINAL Edition
MARSHALL KUBOTA, MD Residency Director, Community Hospital
Published in The Press Democrat (28.10.1996)
Get full text
Published in The Press Democrat (28.10.1996)
Newspaper Article